Avid Bioservices Inc (CDMO)

[goodplenty100]

Biopharm interesting


Regarding MRI w/contrast, gadolinium-based contrast agents.

To address the need for an MRI contrast agent that demonstrates greater effectiveness and lower toxicity, Dr. Sitharaman developed a novel high-performance graphene-based contrast agent that may replace the gadolinium-based agent which is widely used by physicians today. “A graphene-based contrast agent can allow the same clinical MRI performance at substantially lower dosages,” said Dr. Sitharaman.

Then the below is a must read for those like myself who has and continue to undergo MRI's w/contrast.


http://articles.mercola.com/sites/articles/archive/2014/01/09/gadolinium-mri-contrast-agent.aspx